Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (8) Kammertöns, Thomas Dr. (5) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (10) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (9) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (4) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (18) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) (-) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) (-) 2004 (8) 2005 (10) (-) 2006 (1) 2007 (5) 2008 (5) 2009 (2) (-) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (4) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) (-) Molecular Immunology and Gene Therapy (18) 18 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Molecular Immunology and Gene Therapy1999200420062010 Sort: Result score Newest to oldest Oldest to newest January 01, 1999 / Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein March 01, 1999 / J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto August 01, 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel March 01, 2010 / J Mol Med Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia S. Shalapour C. Eckert K. Seeger M. Pfau J. Prada G. Henze T. Blankenstein T. Kammertoens March 15, 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 1999 / Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein
March 01, 1999 / J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
August 01, 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 01, 2010 / J Mol Med Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia S. Shalapour C. Eckert K. Seeger M. Pfau J. Prada G. Henze T. Blankenstein T. Kammertoens
March 15, 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein